Relaxin as a Therapeutic Target for the Cardiovascular Complications of Diabetes
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Relaxin as a Therapeutic Target for the Cardiovascular Complications of Diabetes
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-05-15
DOI
10.3389/fphar.2018.00501
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A new class of drugs for heart failure: SGLT2 inhibitors reduce sympathetic overactivity
- (2018) Motoaki Sano Journal of Cardiology
- H3 relaxin inhibits the collagen synthesis via ROS- and P2X7R-mediated NLRP3 inflammasome activation in cardiac fibroblasts under high glucose
- (2018) Xiaohui Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis
- (2018) M Angelyn Bethel et al. Lancet Diabetes & Endocrinology
- Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy
- (2017) Rebecca H Ritchie et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Relaxin ameliorates high glucose‑induced cardiomyocyte hypertrophy and apoptosis via the Notch1 pathway
- (2017) Xiao Wei et al. Experimental and Therapeutic Medicine
- Macro- and microvascular endothelial dysfunction in diabetes
- (2017) Yi Shi et al. Journal of Diabetes
- Serelaxin treatment reverses vascular dysfunction and left ventricular hypertrophy in a mouse model of Type 1 diabetes
- (2017) Hooi Hooi Ng et al. Scientific Reports
- Endothelial dysfunction and vascular disease - a 30th anniversary update
- (2016) P. M. Vanhoutte et al. Acta Physiologica
- Relaxin deficiency attenuates pregnancy-induced adaptation of the mesenteric artery to angiotensin II in mice
- (2016) Sarah A. Marshall et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Anti-atherosclerotic effects of serelaxin in apolipoprotein E-deficient mice
- (2016) Vedat Tiyerili et al. ATHEROSCLEROSIS
- Vascular actions of relaxin: nitric oxide and beyond
- (2016) C H Leo et al. BRITISH JOURNAL OF PHARMACOLOGY
- Time-dependent activation of prostacyclin and nitric oxide pathways during continuous i.v. infusion of serelaxin (recombinant human H2 relaxin)
- (2016) C H Leo et al. BRITISH JOURNAL OF PHARMACOLOGY
- The actions of relaxin on the human cardiovascular system
- (2016) Mohsin Sarwar et al. BRITISH JOURNAL OF PHARMACOLOGY
- Relaxin suppresses atrial fibrillation in aged rats by reversing fibrosis and upregulating Na+ channels
- (2016) Brian L. Henry et al. HEART RHYTHM
- Protection from cigarette smoke-induced vascular injury by recombinant human relaxin-2 (serelaxin)
- (2016) Alessandro Pini et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
- (2016) Varman T. Samuel et al. JOURNAL OF CLINICAL INVESTIGATION
- Serelaxin (recombinant human relaxin-2) prevents high glucose-induced endothelial dysfunction by ameliorating prostacyclin production in the mouse aorta
- (2016) Hooi Hooi Ng et al. PHARMACOLOGICAL RESEARCH
- Antifibrotic Actions of Serelaxin – New Roles for an Old Player
- (2016) Chrishan S. Samuel et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Serelaxin: A Novel Therapeutic for Vascular Diseases
- (2016) Chen Huei Leo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor, RXFP1
- (2016) Mohammed Akhter Hossain et al. Chemical Science
- Increased superoxide production and altered nitric oxide-mediated relaxation in the aorta of young but not old male relaxin-deficient mice
- (2015) Hooi H. Ng et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- H2 and H3 relaxin inhibit high glucose-induced apoptosis in neonatal rat ventricular myocytes
- (2015) Xiaohui Zhang et al. BIOCHIMIE
- Calcium release channel RyR2 regulates insulin release and glucose homeostasis
- (2015) Gaetano Santulli et al. JOURNAL OF CLINICAL INVESTIGATION
- Vasoconstrictor role of cyclooxygenase-1-mediated prostacyclin synthesis in non-insulin-dependent diabetic mice induced by high-fat diet and streptozotocin
- (2014) Ningxia Zhu et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Molecular mechanisms of diabetic cardiomyopathy
- (2014) Heiko Bugger et al. DIABETOLOGIA
- Serelaxin Is a More Efficacious Antifibrotic Than Enalapril in an Experimental Model of Heart Disease
- (2014) Chrishan S. Samuel et al. HYPERTENSION
- Relaxin Activates Peroxisome Proliferator-activated Receptor γ (PPARγ) through a Pathway Involving PPARγ Coactivator 1α (PGC1α)
- (2014) Sudhir Singh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effects of recombinant human relaxin upon proliferation of cardiac fibroblast and synthesis of collagen under high glucose condition
- (2014) P. Wang et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways
- (2014) Karina Huynh et al. PHARMACOLOGY & THERAPEUTICS
- A Vasoactive Role for Endogenous Relaxin in Mesenteric Arteries of Male Mice
- (2014) Chen Huei Leo et al. PLoS One
- Impact of Diabetes Mellitus on the Clinical Response to Cardiac Resynchronization Therapy in Elderly People
- (2014) Celestino Sardu et al. Journal of Cardiovascular Translational Research
- Acute Intravenous Injection of Serelaxin (Recombinant Human Relaxin‐2) Causes Rapid and Sustained Bradykinin‐Mediated Vasorelaxation
- (2014) Chen Huei Leo et al. Journal of the American Heart Association
- Relaxin Suppresses Atrial Fibrillation by Reversing Fibrosis and Myocyte Hypertrophy and Increasing Conduction Velocity and Sodium Current in Spontaneously Hypertensive Rat Hearts
- (2013) Ashish Parikh et al. CIRCULATION RESEARCH
- Relaxin improves multiple markers of wound healing and ameliorates the disturbed healing pattern of genetically diabetic mice
- (2013) Alessandra Bitto et al. CLINICAL SCIENCE
- Relaxin Treatment Reverses Insulin Resistance in Mice Fed a High-Fat Diet
- (2013) Jeffrey S. Bonner et al. DIABETES
- Treatment for cerebral small vessel disease: effect of relaxin on the function and structure of cerebral parenchymal arterioles during hypertension
- (2013) Siu-Lung Chan et al. FASEB JOURNAL
- Localization of relaxin receptors in arteries and veins, and region-specific increases in compliance and bradykinin-mediated relaxation after in vivo serelaxin treatment
- (2013) Maria Jelinic et al. FASEB JOURNAL
- Impaired effect of relaxin on vasoconstrictor reactivity in spontaneous hypertensive rats
- (2013) Joris van Drongelen et al. PEPTIDES
- Relaxin Prevents Cardiac Fibroblast-Myofibroblast Transition via Notch-1-Mediated Inhibition of TGF-β/Smad3 Signaling
- (2013) Chiara Sassoli et al. PLoS One
- The Anti-fibrotic Hormone Relaxin is not Reno-protective, Despite Being Active, in an Experimental Model of Type 1 Diabetes
- (2013) Su Wong et al. PROTEIN AND PEPTIDE LETTERS
- Identification and optimization of small-molecule agonists of the human relaxin hormone receptor RXFP1
- (2013) Jingbo Xiao et al. Nature Communications
- Relaxin improves TNF-α-induced endothelial dysfunction: the role of glucocorticoid receptor and phosphatidylinositol 3-kinase signalling
- (2012) Thomas Dschietzig et al. CARDIOVASCULAR RESEARCH
- Aging attenuates the vasodilator response to relaxin
- (2011) Joris van Drongelen et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Diabetes Mellitus and Vascular Endothelial Dysfunction: Current Perspectives
- (2011) Dimitris Tousoulis et al. Current Vascular Pharmacology
- Relaxin Induces Rapid Dilation of Rodent Small Renal and Human Subcutaneous Arteries via PI3 Kinase and Nitric Oxide
- (2011) Jonathan T. McGuane et al. ENDOCRINOLOGY
- Relaxin causes selective outward remodeling of brain parenchymal arterioles via activation of peroxisome proliferator-activated receptor-γ
- (2011) Siu-Lung Chan et al. FASEB JOURNAL
- Angiogenic Growth Factors Are New and Essential Players in the Sustained Relaxin Vasodilatory Pathway in Rodents and Humans
- (2011) Jonathan T. McGuane et al. HYPERTENSION
- Relaxin Ameliorates Hypertension and Increases Nitric Oxide Metabolite Excretion in Angiotensin II But Not N ω -Nitro- l -Arginine Methyl Ester Hypertensive Rats
- (2011) Jennifer M. Sasser et al. HYPERTENSION
- Impaired vascular responses to relaxin in diet-induced overweight female rats
- (2011) Joris van Drongelen et al. JOURNAL OF APPLIED PHYSIOLOGY
- Relaxin remodels fibrotic healing following myocardial infarction
- (2011) Chrishan S Samuel et al. LABORATORY INVESTIGATION
- 3′,4′-Dihydroxyflavonol Reduces Superoxide and Improves Nitric Oxide Function in Diabetic Rat Mesenteric Arteries
- (2011) Chen-Huei Leo et al. PLoS One
- Impairment of both nitric oxide-mediated and EDHF-type relaxation in small mesenteric arteries from rats with streptozotocin-induced diabetes
- (2010) CH Leo et al. BRITISH JOURNAL OF PHARMACOLOGY
- Relaxin Therapy Reverses Large Artery Remodeling and Improves Arterial Compliance in Senescent Spontaneously Hypertensive Rats
- (2010) Qi Xu et al. HYPERTENSION
- Endothelial dysfunction in diabetes: multiple targets for treatment
- (2010) Hong Ding et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Diabetic cardiomyopathy, causes and effects
- (2010) Sihem Boudina et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Global estimates of the prevalence of diabetes for 2010 and 2030
- (2009) J.E. Shaw et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Intracellular Angiotensin II Production in Diabetic Rats Is Correlated With Cardiomyocyte Apoptosis, Oxidative Stress, and Cardiac Fibrosis
- (2008) V. P. Singh et al. DIABETES
- Relaxin Ameliorates Fibrosis in Experimental Diabetic Cardiomyopathy
- (2008) Chrishan S. Samuel et al. ENDOCRINOLOGY
- Insulin-Treated Type 2 Diabetes Is Associated with a Decreased Survival in Heart Failure Patients after Cardiac Resynchronization Therapy
- (2008) MAURIZIO MANGIAVACCHI et al. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
- Endothelial dysfunction in the streptozotocin-induced diabetic apoE-deficient mouse
- (2005) Hong Ding et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More